How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,714 results for

Medication Causes of Headache

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. CRACKCast E164 – Plants, Mushrooms, and Herbal Medications

; Exclusion of other causes Systemic features Liver necrosis Occasional degeneration of skeletal & cardiac muscle fibers Micturition difficulty Muscle: Cramps; Cardiac change This post was uploaded and copy-edited by Andrew Guy (Visited 642 times, 1 visits today) Chris Lipp is one of the founding Fathers for CrackCast. He currently divides his time as an EM Physician in Calgary (SHC/FMC) and in Sports Medicine. His interests are in endurance sports, exercise as medicine, and wilderness medical education (...) ingestion will prove to involve a non–life-threatening substance GI symptoms that onset in more than 6 to 8 hours suggest a potentially life-threatening ingestion, such as the cyclopeptide and gyromitrin groups Use local poison control centers, mycologists, and botanists to help identify serious plants and mushrooms that have been ingested. We recommend digital photography with expert consultation Herbal medications are unregulated and may have inherent toxicity, herb-drug interactions, or contaminants

2018 CandiEM

122. CRACKCast E178 – Co-Morbird Medical Emergencies During Pregnancy

(eg, shortness of breath, mild chest pain, edema) can be seen in normal pregnancies, these entities are especially difficult to diagnose. Chronic hypertension is defined as hypertension (>140 mm Hg systolic or >90 mm Hg diastolic) diagnosed prior to pregnancy or before 20 weeks’ gestation. The key question in the ER is: Does that patient have any end organ dysfunction? (head, eyes, heart, lungs, liver, kidney, bone marrow) Medical treatment of uncomplicated chronic hypertension in pregnancy (...) these conditions balancing risks to both mother and fetus. Shownotes – Key Concepts The physiologic demands of pregnancy may cause previously occult medical conditions to become apparent and known problems to deteriorate rapidly. The physiologic adjustments of pregnancy alter the normal ranges for certain laboratory values. The adjusted values need to be considered in the interpretation of results. The possibility of pregnancy should be considered in the differential diagnosis of certain conditions, including

2018 CandiEM

123. CRACKCast E189 – Air Medical Transport

CRACKCast E189 – Air Medical Transport CRACKCast E189 – Air Medical Transport - CanadiEM CRACKCast E189 – Air Medical Transport In , by Adam Thomas June 25, 2018 This episode of CRACKCast covers Chapter 191 in Rosen’s Emergency Medicine (9th Ed.) – Air Medical Transport. Including a review of clinically relevant physics! Fun stuff! Shownotes – Key concepts Boyle’s law and Dalton’s law have the greatest impact and explain the development of hypoxia and most common altitude-related symptoms (...) hypoxia causes headache, nausea, drowsiness, fatigue, unconsciousness, and death. Henry’s law The mass of gas absorbed by a liquid is directly proportional to the partial pressure of the gas above the liquid. Sudden decompression at altitude may result in dysbaric injuries. In scuba diving, rapid ascent can result in gas to come out of solution within the bloodstream, resulting in decompression sickness. From Rosen’s table 191.1 [2] What are four potential body cavities affected by Boyle’s law

2018 CandiEM

124. Renal replacement therapy and conservative management

. 1.1.4 Before starting dialysis in response to symptoms, be aware that some symptoms may be caused by non-renal conditions. T o find out why the committee made the recommendations on indications for starting renal replacement therapy and how they might affect practice, see rationale and impact. 1.2 Preparing for renal replacement therapy or conservative management When to assess When to assess 1.2.1 Start assessment for renal replacement therapy (RRT) or conservative management at least 1 year before (...) considered for a transplant if risk factors for poor outcomes have been identified; these may include: lack of social support neurocognitive issues non-adherence (medicines, diet, hospital appointments) poor understanding of process and complexities of treatment poorly controlled mental health conditions or severe mental illness substance misuse or dependence. T o find out why the committee made the recommendations on preparing for renal replacement therapy or conservative management – how to assess

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

125. Does the Addition of Manipulation Provide Added Benefit to Massage Therapy for Tension-type Headache Patients?

, 2015 Last Update Posted : May 21, 2015 Sponsor: University of Valencia Information provided by (Responsible Party): GEMMA V ESPÍ LÓPEZ, PhD, University of Valencia Study Details Study Description Go to Brief Summary: Objective. To compare the benefits of spinal manipulation combined with massage therapy versus massage alone in patients with tension-type headache (TTH) on the frequency, intensity and disability caused by headache and on cervical range of motion. Method. A factorial, randomized (...) %) and chronic (52.4%) TTH derived from two primary care centres, selected according to the criteria of IHS3,4, and suffering from headache for more than three months. Participants were aged between 18 and 65 years (mean ± SD: 38.9 ± 10.9 years), which included 23 men (21.9%) and 82 women (78.1%). Patients were excluded if they had suspected malignant disease, rheumatoid arthritis, pregnancy, vertigo, continuous intake of prescribed medication or those who received physical therapy in the past 3 months

2015 Clinical Trials

126. Administration of medicinal products by non - medical personnel as part of Clinical Nuclear Medicine Procedures

and assessment’ 4 More detailed information on each licensed drug is available in the manufacturers Summary of Product Characteristics (SPC) and the British National Formulary (BNF) This guidance is not intended to cover medicines used for clinical treatment of adverse events occurring during nuclear medicine procedures (eg. Reaction to any pharmaceutical administered including the relevant radiopharmaceutical, worsening of a pre-existing condition such as asthma) or non-pharmaceutical adjuncts used (...) adverse reaction • Communication with patients; o eliciting relevant information on potential contraindications, allergies and concurrent drug therapy o obtaining consent to administer the medicine o advice to patient about potential delayed affects and actions required • Intravenous injection and infusion • Intermediate Life Support • Relevant documentation MEDICINES USED IN NUCLEAR MEDICINE AS PART OF THE CLINICAL PROCEDURE (2013) [ * Medicines for which this draft contains sample templates] Page 6

2013 British Nuclear Medicine Society

127. Headache, Diagnosis and Treatment of

. Together, we aim to improve care and reduce costs for our patients, families and communities. e Guidelines Headache, Diagnosis and Treatment of REVISION DATE: JANUARY 2013 / ELEVENTH EDITION GUIDELINE SUMMARY Scope and Target Population Patients age 12 years and older who present with headache. For the purpose of this guideline, pain that primarily involves the back of the neck and only involves the head to a limited extent is not considered a headache. This guideline does not specifically address (...) and clinicians. Most headaches characterized as “sinus headaches” are migraines. Early treatment of migraines with effective medications improves a variety of outcomes including duration, severity and associated disability. Drug treatment of acute headache should generally not exceed more than two days per week on a regular basis. More frequent treatment other than this may result in medication-overuse chronic daily headaches. Inability to work or carry out usual activities during a headache is an important

2013 Institute for Clinical Systems Improvement

128. Negative pressure wound therapy for wounds healing by secondary intention

in Health Care (IQWiG) - ii - This report was prepared in collaboration with external experts. The responsibility for the contents of the report lies solely with IQWiG. According to §139b (3) No. 2 of Social Code Book (SGB) V, Statutory Health Insurance, external experts who are involved in the Institute’s research commissions must disclose “all connections to interest groups and contract organizations, particularly in the pharmaceutical and medical devices industries, including details on the type (...) therapy in patients with wounds healing by secondary intention with regard to patient-relevant out- comes. The benefit assessment of negative pressure wound therapy in patients with wounds healing by primary intention was conducted as part of project N17-01B. Conclusion For a relevant percentage of studies on negative pressure wound therapy of wounds healing by secondary intention, no data are available. Since at 24%, the calculated data gap can cause relevant bias (publication bias), the certainties

2019 Institute for Quality and Efficiency in Healthcare (IQWiG)

129. Cohort study: Third-generation CT has 100% sensitivity and specificity for identifying subarachnoid haemorrhage when it is carried out within 6 h of headache onset

: prospective cohort study. Context A complaint of acute onset headache mandates that subarachnoid haemorrhage (SAH) be excluded as the cause. Because of the less than perfect sensitivity of unenhanced head CT, standard practice is to follow a negative CT with lumbar puncture (LP) to exclude subarachnoid haemorrhage. Improvements in CT technology have raised the question of whether modern third-generation CT scanners are sensitive enough to adequately exclude subarachnoid haemorrhage. Methods (...) Cohort study: Third-generation CT has 100% sensitivity and specificity for identifying subarachnoid haemorrhage when it is carried out within 6 h of headache onset Third-generation CT has 100% sensitivity and specificity for identifying subarachnoid haemorrhage when it is carried out within 6 h of headache onset | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time

2012 Evidence-Based Medicine

130. Medication Causes of Headache

Medication Causes of Headache Medication Causes of Headache Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Medication Causes (...) with ) Diclofenac (Voltaren) ( ) Pulmonary Agents ( ) Endocrine Agents CNS Agents s ( ) III. Causes: Headaches related to medication or Substance Withdrawal Chemicals withdrawal Miscellaneous Agents withdrawal IV. References Goldman (2000) Cecil Medicine, Saunders, p. 2066 Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Medication Causes of Headache." Click on the image (or right click) to open the source website in a new browser window

2015 FP Notebook

131. A Review of Herbal Medicine in Iranian Traditional Manuscripts for Treatment of Participatory Gastric Headache Full Text available with Trip Pro

A Review of Herbal Medicine in Iranian Traditional Manuscripts for Treatment of Participatory Gastric Headache Participatory gastric headache is a type of headache described in Iranian traditional medicine. It is defined as a headache not originated from the head and neck disorders; rather the pain in the head is caused by gastric dysfunction and its disorders. Treatment of this type of headache is completely reliant on the treatment of the gastric complaint. Reviewing Iranian traditional (...) medicine (ITM) literature, a broad spectrum of herbal medicines that could be useful in the treatment of this type of headache is described. Accordingly, this review was performed to gather and discuss the therapeutic management of this disorder in ITM and evaluating related characteristics of each medicinal herb.In this study, medicinal plants prescribed for gastric headache from different ancient Iranian literature is documented. The botanical name, family name, part used, temperaments, rout

2016 Iranian journal of medical sciences

132. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy Subjects. (Abstract)

was administered alone or with single-dose lorazepam, zolpidem, tramadol, ethanol, or interacting drug placebo. Safety was assessed and serial samples for pharmacokinetic parameters were collected for up to 48 hours postdose. PD assessments included body sway (except tramadol), digit symbol substitution test, vertigo symptom scale short form, brief ataxia rating scale, and the Bond and Lader visual analog scale. Coadministration of mirogabalin with any of the 4 drugs did not cause any clinically relevant (...) Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy Subjects. Four randomized, double-blind, placebo-controlled, 4-period drug-drug interaction studies were conducted in healthy subjects to evaluate the pharmacokinetic and pharmacodynamic (PD) interactions between mirogabalin and commonly used central nervous system depressants. Mirogabalin or placebo

2018 Clinical pharmacology in drug development Controlled trial quality: predicted high

133. Impact of Medical Conditions and Medications on Road Traffic Safety Full Text available with Trip Pro

Impact of Medical Conditions and Medications on Road Traffic Safety Many medical conditions and medicines with therapeutic importance have been shown to impair driving skills, causing road traffic accidents, which leads to great human and economic suffering in Oman. The primary purpose of this study was to assess retrospectively the extent of medical conditions and medications influencing road traffic safety among drivers involved in road accidents.We conducted a retrospective study among 951 (...) (9.4%). Loss of control was contributed to 38.5% of cases followed by dizziness (25.6%), sleep amnesia (10.3%), and blurred vision (7.7%). Other effects blamed by victimized drivers include vertigo, phonophobia, photophobia, back pain, loss of sensation, and headache accounting for 17.9% of cases.Medical conditions and medications influence road traffic safety to some extent in Oman.

2018 Oman medical journal

134. Emerging Drugs for Duchenne Muscular Dystrophy

and mortality. DMD is caused by a mutation of the dystrophin gene that results in a lack of dystrophin, a protein that is necessary for muscle cell function. The mainstays of current therapy to treat DMD are corticosteroids and assistive devices. This bulletin focuses on new and emerging drugs for DMD with completed phase IIb or phase III trials and includes ataluren (nonsense mutation suppression), eteplirsen (exon 51 skipping), and idebenone (adenosine triphosphate [ATP] modulation). Ezutromid (utrophin (...) regulatory approval, a major barrier to the uptake of novel therapies for DMD is likely to be cost. Furthermore, there is the possibility for some of the medications to be used in combination, which will increase the cost further. Criteria will need to be determined to establish which patients are more likely to benefit, and to identify when a drug is no longer beneficial. Administering medication to children can be challenging. Idebenone and ataluren are orally administered and require multiple daily

2017 CADTH - Issues in Emerging Health Technologies

135. Emerging Drugs for Duchenne Muscular Dystrophy

and mortality. DMD is caused by a mutation of the dystrophin gene that results in a lack of dystrophin, a protein that is necessary for muscle cell function. The mainstays of current therapy to treat DMD are corticosteroids and assistive devices. This bulletin focuses on new and emerging drugs for DMD with completed phase IIb or phase III trials and includes ataluren (nonsense mutation suppression), eteplirsen (exon 51 skipping), and idebenone (adenosine triphosphate [ATP] modulation). Ezutromid (utrophin (...) regulatory approval, a major barrier to the uptake of novel therapies for DMD is likely to be cost. Furthermore, there is the possibility for some of the medications to be used in combination, which will increase the cost further. Criteria will need to be determined to establish which patients are more likely to benefit, and to identify when a drug is no longer beneficial. Administering medication to children can be challenging. Idebenone and ataluren are orally administered and require multiple daily

2017 CADTH - Issues in Emerging Health Technologies

136. Chronic pain disorder medical treatment guideline.

of individual and/or group patient education as a means of facilitating self-management of symptoms Psychological or psychosocial screening should be performed on all chronic pain patients. Acupuncture Acupuncture is recommended for subacute or chronic pain patients who are trying to increase function and/or decrease medication usage and have an expressed interest in this modality. It is also recommended for subacute or acute pain for patients who cannot tolerate nonsteroidal anti-inflammatory drugs (NSAIDs (...) behavioral therapy over biofeedback ). See the original guideline document for indications, types of biofeedback, time to produce effect, frequency, and optimum and maximum duration. Complementary Medicine Evidence Statements Regarding Complementary Medicine Some Evidence A 10-week Tai Chi program was effective for improving pain symptoms and disability compared with usual care controls for those who have chronic low back pain symptoms (Design: Assessor single-blind randomized controlled trial ). See

2017 National Guideline Clearinghouse (partial archive)

137. Complex regional pain syndrome/reflex sympathetic dystrophy medical treatment guideline.

and/or group patient education as a means of facilitating self-management of symptoms. Psychological or psychosocial screening should be performed on all chronic pain patients. Acupuncture Acupuncture is recommended for subacute or chronic pain patients who are trying to increase function and/or decrease medication usage and have an expressed interest in this modality. It is also recommended for subacute or acute pain for patients who cannot tolerate nonsteroidal anti-inflammatory drugs (NSAIDs) or other (...) medications, and it should generally be used in conjunction with manipulative and physical therapy/rehabilitation. Refer to the Division's for indications, evidence, and time frames. Biofeedback Biofeedback is a form of behavioral medicine that helps patients learn self-awareness and self-regulation skills for the purpose of gaining greater control of their physiology, such as muscle activity, brain waves, and measures of autonomic nervous system activity. Stress-related psycho-physiological reactions may

2017 National Guideline Clearinghouse (partial archive)

138. Management of Suspected Opioid Overdose with Naloxone by Emergency Medical Services Personnel

associated with prescription and illicit opioids have been characterized by the U.S. Department of Health and Human Services as a national crisis. 1 Since 2000, the rate of overdose deaths involving opioids has increased four-fold. 2,3 Drug overdose deaths are now the leading cause of injury-related death in the United States. 4 Overdoses due to opioids cause respiratory depression that can progress to cardiac arrest if untreated. In 2015, the number of drug overdose deaths involving prescription (...) , response to naloxone (e.g., based on Glasgow Coma Scale score), other substances and drugs involved in overdose, or other factors. Studies should supplement use of medical examiner and hospital records to identify outcomes with formal followup assessments, and evaluate outcomes such as linkage to treatment for opioid use disorder and risk of future overdose episodes, in addition to serious adverse outcomes such as death. Conclusions Low-strength evidence suggests that IN naloxone at a dose of 2 mg

2017 Effective Health Care Program (AHRQ)

139. Safe Medication Use in the ICU Full Text available with Trip Pro

to recognize preventing harm resulting from adverse drug events (ADEs) may be circumvented by averting medication errors (MEs) with appropriate medication use, planning, and monitoring ( ). Frequency of MEs is estimated to occur in 19% of hospitalized patients ( ). About one in every five medication doses administered to hospitalized patients are considered MEs ( ). MEs and ADEs are a common and significant concern in the ICU since they represent a leading cause of iatrogenic errors in the critically ill (...) fatalities ranked between the fourth and sixth leading causes of death in the United States ( ). Therefore, drug-induced fatalities in the ICU are a pragmatic concern despite the paucity of data. Patient safety is a priority for several government agencies, nonprofit organizations, and regulatory bodies considering the detrimental and financial consequences associated with MEs and ADEs. The Institute of Medicine (IOM) has recommended government agencies such as the Food and Drug Administration (FDA

2017 Society of Critical Care Medicine

140. American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

addresses the perioperative use of antirheumatic drug therapy including traditional disease- modifying antirheumatic drugs, biologic agents, tofacitinib, and glucocorticoids in adults with RA, SpA, JIA, or SLE who are undergoing elective THA or TKA. It provides recommendations regarding when to continue, when to with- hold, and when to restart these medications, and the optimal perioperative dosing of glucocorticoids. The guideline includes 7 recommendations, all of which are conditional and based (...) . This guideline does not address indications for THA or TKA, medical decisions unrelated to antirheumatic drug therapy, choice of implant, surgical approach, or perioper- ative evaluation and management of concurrent disease, such as that affecting the cervical spine of patients with RA. Although patients with RA, SpA, JIA, or SLE should be assessed for risk of venous thromboembolism and major acute coronary event (8,25), this guideline does not address cardiac risk assessment or perioperative venous

2017 American College of Rheumatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>